BioCentury | Mar 28, 2019
Financial News

Antidepressant developer ATAI raises $43M series B round

...participating were Apeiron Investment Group, which is the family office of ATAI co-founder Christian Angermayer; Bail Capital...
Items per page:
1 - 1 of 1
BioCentury | Mar 28, 2019
Financial News

Antidepressant developer ATAI raises $43M series B round

...participating were Apeiron Investment Group, which is the family office of ATAI co-founder Christian Angermayer; Bail Capital...
Items per page:
1 - 1 of 1